ConcertAI subsidiary TeraRecon is integrating Us2.ai's echocardiogram viewing and measurement tools into its Eureka Clinical AI software-as-a-service platform.
Designed to expedite access to echocardiogram reports and critical diagnostics in the acute and postacute care phases, Us2.ai's artificial intelligence (AI)-based software can produce complete echocardiography reports in less than two minutes, according to the vendors. It recognizes and analyzes 2D and Doppler echocardiography images, generating the comprehensive cardiac measurements needed for the diagnosis, prediction, and prognosis of heart disease and pulmonary hypertension, the firms said.
